tilorone has been researched along with Cancer of Larynx in 1 studies
Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karimova, FS | 1 |
| Ivanchenko, GF | 1 |
| Grigorian, SS | 1 |
1 other study available for tilorone and Cancer of Larynx
| Article | Year |
|---|---|
[The treatment of laryngeal papillomatosis with interferon inducers].
Topics: Acridines; Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Humans; In | 2000 |